Navigation Links
Bacteria responsible for gum disease facilitates rheumatoid arthritis
Date:9/12/2013

LOUISVILLE, Ky. - Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis (RA) - the microbiological mechanisms have remained unclear.

In an article published today in PLOS Pathogens, University of Louisville School of Dentistry Oral Health and Systemic Diseases group researcher Jan Potempa, PhD, DSc, and an international team of scientists from the European Union's Gums and Joints project have uncovered how the bacterium responsible for periodontal disease, Porphyromonas gingivalis worsens RA by leading to earlier onset, faster progression and greater severity of the disease, including increased bone and cartilage destruction.

The scientists found that P. gingivalis produces a unique enzyme, peptidylarginine deiminanse (PAD) which then enhances collagen-induced arthritis (CIA), a form of arthritis similar to RA produced in the lab. PAD changes residues of certain proteins into citrulline, and the body recognizes citullinated proteins as intruders, leading to an immune attack. In RA patients, the subsequent result is chronic inflammation responsible for bone and cartilage destruction within the joints.

Potempa and his team studied another oral bacterium, Prevotella intermedia for the same affect, but learned it did not produce PAD, and did not affect CIA.

"Taken together, our results suggest that bacterial PAD may constitute the mechanistic link between P. gingivalis periodontal infection and rheumatoid arthritis, but this ground-breaking conclusion will need to be verified with further research," he said.

Potempa said he is hopeful these findings will shed new light on the treatment and prevention of RA.

Studies indicate that compared to the general population, people with periodontal disease have an increased prevalence of RA and, periodontal disease is at least two times more prevalent in RA patients. Other research has shown that a P. gingivalis infection in the mouth will precede RA, and the bacterium is the likely culprit for onset and continuation of the autoimmune inflammatory responses that occur in the disease.


'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Related biology news :

1. Stomach bacteria switch off human immune defences to cause disease
2. Rich or poor in gut bacteria brings new vision for obesity treatment
3. Bacterial toxins cause deadly heart disease
4. UC Davis researchers discover molecular target for the bacterial infection brucellosis
5. High-angle helix helps bacteria swim
6. Newly discovered bacterial partnership changes ocean chemistry
7. Bacterial blockade
8. Study finds depletion of alveolar macrophages linked to bacterial super-infections
9. New methods to visualize bacterial cell-to-cell communication
10. Bacteria from Salar de Uyuni in Bolivia conceal bioplastic
11. CWRU dental researchers NIDCR grant targets oral bacteria and fetal death link
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... Dec, 20, 2016   Valencell , the ... and STMicroelectronics (NYSE: STM), a global semiconductor ... applications, announced today the launch of a new, ... wearables that includes ST,s compact SensorTile ... biometric sensor system. Together, SensorTile and Benchmark ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical ... 12.14 billion by 2021 from USD 5.31 billion in 2016, at ... ... mainly driven by technological advancements in medical devices, launch of a ... preference for wireless connectivity among healthcare providers, and increasing focus on ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... ... January 20, 2017 , ... G&L Scientific Inc, a leading ... http://www.gandlscientific.com ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening ... contractors. This is the latest step in G&Lā€™s expansion of its global clinical ...
(Date:1/21/2017)... Jan. 20, 2017 Interpace Diagnostics Group, ... that provides clinically useful molecular diagnostic tests and ... into a securities purchase agreement with three  institutional ... of common stock in a registered direct offering.  ... agreed to sell to the same investors warrants ...
(Date:1/21/2017)... --  Boston Biomedical , an industry leader in the ... pathways, today presented data from two clinical studies for ... Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in ... In a Phase Ib/II study of napabucasin ā€“ an ... pathways by targeting STAT3 ā€“ colorectal cancer (CRC) patients ...
(Date:1/20/2017)... BOSTON , Jan. 20, 2017 ... acquisition of Gen9, a pioneer in the synthesis ... Gen9,s unique expertise in assembling pathway-length synthetic DNA ... speed and capacity in the construction of new ... of industries. "Gen9 was founded to ...
Breaking Biology Technology: